Genomics

Dataset Information

0

MiRNA expression signatures in chronic hepatitis B (CHB) treated with nucleos(t)ide analogues (NA)


ABSTRACT: Hepatitis B virus (HBV) infection is one of the major causes of hepatocellular carcinoma (HCC). Nucleos(t)ide analogue (NA) therapy is effective to reduce the HCC incidence, while it doesn’t completely prevent HCC. In this study, we explored the involvement of microRNA (miRNA) in the post-NA treatment HCC development. Chronic hepatitis B (CHB) patients who received NA treatment (n = 18) were divided into 2 groups: those who didn’t develop HCC during the follow-up period (non-HCC group) and those who developed HCC after treatment (HCC group). Liver specimens were obtained before and after NA therapy, and HCC tissues were also obtained from the HCC group patients. Normal liver tissues were also obtained from 4 liver hemangioma patients who underwent surgical resection. miRNA expression was analyzed using Agilent miRNA microarray V3.

ORGANISM(S): Homo sapiens

PROVIDER: GSE110217 | GEO | 2018/09/23

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| PRJNA433193 | ENA
2015-04-11 | E-GEOD-67764 | biostudies-arrayexpress
2010-04-10 | E-GEOD-21279 | biostudies-arrayexpress
2013-11-14 | E-GEOD-44074 | biostudies-arrayexpress
2013-02-20 | E-GEOD-40744 | biostudies-arrayexpress
2009-01-18 | E-GEOD-14323 | biostudies-arrayexpress
2022-07-13 | PXD033752 | Pride
2013-11-14 | GSE44074 | GEO
2010-04-10 | GSE21279 | GEO
2013-10-25 | E-GEOD-41874 | biostudies-arrayexpress